Why did Eli Lilly halt 340B drug discounts for certain hospitals?

Eli Lilly stopped 340B drug discounts for hospitals that failed to submit required claims data, following a June ultimatum tied to its new data policy. The decision intensifies a legal and regulatory dispute between drugmakers and hospitals over data transparency, with industry groups urging federal intervention and regulators expected to weigh in next.